SecurityPRSS / CafePress Inc. (12769A103)
IndustryMiscellaneous Retail
Common Shares Outstanding16,947,264 shares (as of 2017-12-31)
Total Insiders31
Total Directors11
Total Officers6

Stock Insider Trading (from SEC Form 4)

CafePress Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

PRSS / CafePress Inc. insiders include SEQUOIA CAPITAL IX, Jackson Garett, Arico Mary Ann, Shannon Roger D, SEQUOIA CAPITAL FRANCHISE PARTNERS LP, Milliner Philip, SUBIN NEIL S, SEQUOIA TECHNOLOGY PARTNERS XI, SC IX.I MANAGEMENT, LLC, SEQUOIA CAPITAL XI PRINCIPALS FUND, SEQUOIA CAPITAL ENTERPRENEURS ANNEX FUND, Kim Soohyung Buss Brad W, Furber Laurie, CONNOLLY PAT, SC XI MANAGEMENT LLC, MCBRIDE KENNETH THOMAS, Swinmurn Nick, MILLER LLOYD I III, Barton Robert D, Lysonge Ekumene M, SEQUOIA CAPITAL FRANCHISE FUND LP, MORITZ MICHAEL J, ALLEN ANTHONY C, Jain Maheesh, Standard General L.P., and SEQUOIA CAPITAL XI, Howe Alan B, Durham Fred E. III, LEONE DOUGLAS M, SCFF MANAGEMENT LLC, .

Insider Roster

Insider Dir Off 10% Shares Owned
Lysonge Ekumene M VP, General Counsel, Secretary
X 28,087
Milliner Philip CFO
X 27,730
Howe Alan B Director
X
SUBIN NEIL S 10% Owner
X 3,396,420
Barton Robert D Chief Operating Officer
X 333
Standard General L.P. 10% Owner
Kim Soohyung See Footnote 3, Director, 10% Owner
X 5,000,000
Furber Laurie Director
X 13,779
SC XI MANAGEMENT LLC 10% Owner
MORITZ MICHAEL J 10% Owner
LEONE DOUGLAS M 10% Owner
X 0
Durham Fred E. III Chief Executive Officer, Director, 10% Owner
X X X 2,545,431
MILLER LLOYD I III 10% Owner
X 3,359,535
ALLEN ANTHONY C Director
X 48,062
Shannon Roger D Director
X 26,119
MCBRIDE KENNETH THOMAS Director
X 48,062
Swinmurn Nick Director
X 48,062
CONNOLLY PAT Director
X 125,288
Arico Mary Ann Director
X 26,119
Jain Maheesh Chief Marketing Officer, 10% Owner
X X
Jackson Garett Chief Financial Officer
X
Buss Brad W Director
X
LEONE DOUGLAS M Director, 10% Owner
X X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-04-03 4 Lysonge Ekumene M F D 1.35 -825 28,087
2018-03-02 4 Milliner Philip F D 1.37 -378 27,730
2018-02-16 4 Lysonge Ekumene M F D 1.50 -582 28,912
2018-01-03 4 Barton Robert D F D 1.85 -863 333
2018-01-03 4 Milliner Philip F D 1.85 -2,996 28,108
2018-01-03 4 Lysonge Ekumene M F D 1.85 -1,771 29,494
2017-12-01 4 Milliner Philip F D 1.80 -334 31,104
2017-10-03 4 Barton Robert D F D 1.81 -825 1,196
2017-11-20 4 Lysonge Ekumene M F D 1.85 -534 31,265
2017-10-03 4 Lysonge Ekumene M F D 1.81 -757 31,799
2017-10-03 4 Milliner Philip F D 1.81 -980 31,438
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -39,738 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -136,865 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -1,258,026 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -393,497 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -122,968 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -901,768 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -16,396 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -39,738 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -136,865 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -1,258,026 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -393,497 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -122,968 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -901,768 0
2017-09-29 4 SC XI MANAGEMENT LLC S I 1.7529 -16,396 0
2017-09-21 4 Furber Laurie A D 2.08 133,779 13,779
2017-09-22 4 SC XI MANAGEMENT LLC S I -124 39,738
2017-09-22 4 SC XI MANAGEMENT LLC S I -427 136,865
2017-09-22 4 SC XI MANAGEMENT LLC S I -3,928 1,258,026
2017-09-22 4 SC XI MANAGEMENT LLC S I -1,229 393,497
2017-09-22 4 SC XI MANAGEMENT LLC S I -384 122,968
2017-09-22 4 SC XI MANAGEMENT LLC S I -2,815 901,768
2017-09-22 4 SC XI MANAGEMENT LLC S I -51 16,396
2017-09-21 4 SC XI MANAGEMENT LLC S I -10 39,862
2017-09-21 4 SC XI MANAGEMENT LLC S I -33 137,292
2017-09-21 4 SC XI MANAGEMENT LLC S I -307 1,261,954
2017-09-21 4 SC XI MANAGEMENT LLC S I -96 394,726
2017-09-21 4 SC XI MANAGEMENT LLC S I -30 123,352
2017-09-21 4 SC XI MANAGEMENT LLC S I -220 904,583
2017-09-21 4 SC XI MANAGEMENT LLC S I -4 16,447
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -331 39,872 87,320
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -1,138 137,325 300,742
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -10,465 1,262,261 2,764,352
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -3,273 394,822 864,660
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -1,023 123,382 270,207
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -7,501 904,803 1,981,519
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -136 16,451 36,028
2017-09-22 4 SC XI MANAGEMENT LLC S I -124 39,738
2017-09-22 4 SC XI MANAGEMENT LLC S I -427 136,865
2017-09-22 4 SC XI MANAGEMENT LLC S I -3,928 1,258,026
2017-09-22 4 SC XI MANAGEMENT LLC S I -1,229 393,497
2017-09-22 4 SC XI MANAGEMENT LLC S I -384 122,968
2017-09-22 4 SC XI MANAGEMENT LLC S I -2,815 901,768
2017-09-22 4 SC XI MANAGEMENT LLC S I -51 16,396
2017-09-21 4 SC XI MANAGEMENT LLC S I -10 39,862
2017-09-21 4 SC XI MANAGEMENT LLC S I -33 137,292
2017-09-21 4 SC XI MANAGEMENT LLC S I -307 1,261,954
2017-09-21 4 SC XI MANAGEMENT LLC S I -96 394,726
2017-09-21 4 SC XI MANAGEMENT LLC S I -30 123,352
2017-09-21 4 SC XI MANAGEMENT LLC S I -220 904,583
2017-09-21 4 SC XI MANAGEMENT LLC S I -4 16,447
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -331 39,872 87,320
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -1,138 137,325 300,742
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -10,465 1,262,261 2,764,352
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -3,273 394,822 864,660
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -1,023 123,382 270,207
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -7,501 904,803 1,981,519
2017-09-20 4 SC XI MANAGEMENT LLC S I 2.19 -136 16,451 36,028
2017-09-05 4 Durham Fred E. III P D 2.03 15,667 2,545,431 5,167,225
2017-08-31 4 Milliner Philip F D 2.10 -1,279 32,418
2016-08-29 4 Milliner Philip A D 3.06 22,000 35,836
2016-08-29 4 Milliner Philip A D 3.06 13,836 13,836
2017-08-30 4 Durham Fred E. III P D 2.10 13,163 2,529,764 5,312,504
2017-08-29 4 Durham Fred E. III P D 2.10 722 2,516,601 5,284,862
2017-08-24 4 Durham Fred E. III A D 2.10 11,107 2,515,879
2017-08-24 4 Durham Fred E. III P D 2.1325 27,096 2,504,772 5,341,426
2017-08-23 4 Durham Fred E. III P D 1.99 2,512 2,477,676 4,930,575
2017-08-21 4 Durham Fred E. III P D 1.96 1,537 2,475,164 4,851,321
2017-08-18 4 Durham Fred E. III P D 1.9652 2,856 2,473,627 4,861,172
2017-08-15 4 Lysonge Ekumene M F D 1.8799 -543 32,556
2017-08-17 4 Durham Fred E. III P D 1.9509 18,599 2,470,771 4,820,227
2017-08-16 4 Durham Fred E. III P D 1.9076 3,517 2,452,172 4,677,763
2017-08-15 4 Durham Fred E. III P D 1.8899 21,017 2,448,655 4,627,713
2017-08-11 4 Durham Fred E. III P D 1.8238 19,901 2,427,638 4,427,526
2017-08-10 4 Durham Fred E. III P D 1.8398 30,373 2,407,737 4,429,755
2017-08-09 4 Durham Fred E. III P D 1.8722 20,081 2,377,364 4,450,901
2017-08-08 4 Durham Fred E. III P D 1.8285 24,602 2,357,283 4,310,292
2017-08-07 4 Durham Fred E. III P D 1.80 1,742 2,332,681 4,198,826
2017-08-04 4 Durham Fred E. III P D 1.8153 5,300 2,330,939 4,231,354
2017-08-03 4 Durham Fred E. III P D 1.75 15,019 2,325,639 4,069,868
2017-08-02 4 Durham Fred E. III P D 1.75 200 2,310,620 4,043,585
2017-07-05 4 Milliner Philip F D 2.4879 -962 33,697
2017-07-05 4 Barton Robert D F D 2.4879 -979 2,021
2017-07-05 4 Lysonge Ekumene M F D 2.4879 -743 33,099
2017-06-16 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.45 11,885 3,371,420 8,259,979
2017-06-15 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.45 34,132 3,359,535 8,230,861
2017-06-08 4 Durham Fred E. III P D 2.50 1,400 2,310,420 5,776,050
2017-05-30 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.54 12,689 3,325,403 8,446,524
2017-05-26 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.54 2,210 3,312,714 8,414,294
2017-05-25 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.54 10,101 3,310,504 8,408,680
2017-05-17 4 Durham Fred E. III P D 2.50 900 2,309,020 5,772,550
2017-05-15 4 Lysonge Ekumene M F D 2.61 -594 33,842
2017-02-13 4 Lysonge Ekumene M F D 3.3398 -654 34,436
2017-05-09 4 Arico Mary Ann A D 2.68 26,119 26,119
2017-05-09 4 CONNOLLY PAT A D 2.68 21,455 125,288
2017-05-09 4 CONNOLLY PAT A D 2.68 26,119 103,833
2017-05-09 4 Swinmurn Nick A D 2.68 26,119 48,062
2017-05-09 4 MCBRIDE KENNETH THOMAS A D 2.68 26,119 48,062
2017-05-09 4 Shannon Roger D A D 2.68 26,119 26,119
2017-05-09 4 ALLEN ANTHONY C A D 2.68 26,119 48,062
2017-05-05 4 Durham Fred E. III P D 2.7018 31,518 2,308,120 6,236,079
2017-05-03 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.6109 111,900 3,300,403 8,617,022
2017-04-13 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.80 15,822 3,188,503 8,927,808
2017-04-12 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.80 10,658 3,172,681 8,883,507
2017-04-04 4 Lysonge Ekumene M F D -910 35,090
2017-04-04 4 Milliner Philip F D 2.92 -1,177 34,659
2017-01-04 4 Durham Fred E. III P D 2.9989 1,780 2,289,035 6,864,587
2016-12-08 4 Durham Fred E. III P D 2.9982 3,000 2,280,098 6,836,190
2016-12-30 4 Durham Fred E. III P D 2.9482 3,000 2,287,255 6,743,285
2016-12-28 4 Durham Fred E. III P D 2.9928 857 2,284,255 6,836,318
2016-12-16 4 Durham Fred E. III P D 2.9997 1,400 2,283,398 6,849,509
2016-12-13 4 Jain Maheesh G D -12,510 45,001
2016-12-12 4 Durham Fred E. III P D 2.9537 1,900 2,281,998 6,740,337
2016-12-06 4 Durham Fred E. III P D 2.9749 498 2,277,098 6,774,139
2016-11-22 4 Durham Fred E. III P D 2.8960 8,000 2,271,660 6,578,727
2016-11-23 4 Durham Fred E. III P D 2.8800 5,000 2,268,660 6,533,741
2016-11-18 4 Durham Fred E. III P D 2.8913 3,000 2,263,660 6,544,920
2016-11-18 4 Durham Fred E. III P D 2.9000 5,000 2,260,660 6,555,914
2016-11-17 4 MILLER LLOYD I III By Milfam II L.P. P I 2.80 140 3,162,023 8,853,664
2016-11-16 4 Durham Fred E. III P D 2.8545 3,000 2,255,660 6,438,781
2016-11-16 4 Durham Fred E. III P D 2.8246 13,694 2,252,660 6,362,863
2016-11-16 4 MILLER LLOYD I III By Milfam II L.P. P I 2.80 2,647 3,161,883 8,853,272
2016-11-15 4 MILLER LLOYD I III By Milfam II L.P. P I 2.80 10,733 3,159,236 8,845,861
2016-11-14 4 Durham Fred E. III P D 2.8802 3,000 2,238,966 6,448,670
2016-11-10 4 Durham Fred E. III P D 3.0000 400 2,235,966 6,707,898
2016-11-10 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.00 7,800 3,148,503 9,445,509
2016-11-09 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.00 16,400 3,140,703 9,422,109
2016-11-08 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.0064 2,300 3,124,303 9,392,905
2016-11-02 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.00 2,999 3,122,003 9,366,009
2016-10-27 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.00 3,300 3,119,004 9,357,012
2016-10-26 4 Jain Maheesh A D 3.0000 100 1,935,345
2016-09-16 4 Durham Fred E. III P D 2.9857 532 2,235,566 6,674,729
2016-09-16 4 Jain Maheesh P D 2.9940 500 1,935,245 5,794,124
2016-09-14 4 Jain Maheesh P D 3.0000 5 1,934,745 5,804,235
2016-09-12 4 Durham Fred E. III P D 3.0000 141 2,235,034 6,705,102
2016-09-12 4 Jain Maheesh P D 3.0000 306 1,934,740 5,804,220
2016-09-06 4 Durham Fred E. III P D 3.0000 337 2,234,893 6,704,679
2016-09-06 4 Jain Maheesh P D 3.0000 700 33,600 100,800
2016-08-31 4 MILLER LLOYD I III By Milfam II L.P. P I 2.97 11,554 3,115,704 9,253,641
2016-08-30 4 Jain Maheesh P D 3.0000 400 32,900 98,700
2016-08-26 4 Durham Fred E. III P D 2.9660 3,000 2,234,556 6,627,693
2016-08-26 4 Jain Maheesh P D 2.9830 500 32,500 96,948
2016-08-09 4 Jackson Garett F D 2.3200 -438 74,407
2016-07-31 4 Jackson Garett F D 3.1200 -521 74,845
2016-06-21 4 Jackson Garett F D 3.0300 -460 75,366
2016-05-13 4 Jackson Garett F D 3.2000 -337 75,826
2016-04-30 4 Jackson Garett F D 3.5700 -511 76,163
2016-03-21 4 Jackson Garett F D 3.6200 -454 54,674
2016-02-13 4 Jackson Garett F D 3.3400 -395 55,128
2016-01-31 4 Jackson Garett F D 3.4200 -634 55,523
2015-12-21 4 Jackson Garett F D 3.6000 -465 56,157
2015-11-13 4 Jackson Garett F D 3.9000 -343 56,622
2016-08-24 4 Durham Fred E. III P D 2.9940 1,342 2,231,556 6,681,279
2016-08-24 4 Jain Maheesh P D 3.0000 500 32,000 96,000
2016-08-22 4 Durham Fred E. III P D 2.9784 3,000 2,230,214 6,642,469
2016-08-22 4 Jain Maheesh P D 2.9940 500 31,500 94,311
2016-08-18 4 Durham Fred E. III P D 2.9920 3,000 2,227,214 6,663,824
2016-08-18 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.90 600 3,104,150 9,002,035
2016-08-18 4 Jain Maheesh P D 3.0000 500 31,000 93,000
2016-08-17 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 2.90 14,900 3,103,550 9,000,295
2016-08-16 4 Durham Fred E. III P D 2.9536 3,000 2,224,214 6,569,438
2016-08-16 4 Jain Maheesh P D 2.9870 1,400 30,500 91,104
2016-08-10 4 Durham Fred E. III A D 2.9707 2,300 2,221,214
2016-08-10 4 Jain Maheesh A D 2.9700 6,600 29,100
2016-06-29 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.01 8,500 3,063,650 9,221,586
2016-06-28 4 MILLER LLOYD I III By Milfam I L.P. P I 3.00 25,000 2,242,300 6,726,900
2016-06-28 4 Durham Fred E. III P D 2.9818 3,000 2,218,914 6,616,358
2016-06-28 4 Jain Maheesh P D 2.9900 500 22,500 67,275
2016-06-27 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.00 25,000 3,055,150 9,165,450
2016-06-16 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.10 21,800 3,030,150 9,393,465
2016-06-14 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.10 2,600 3,008,350 9,325,885
2016-06-13 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.10 25,600 3,005,750 9,317,825
2016-05-24 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.099 18,700 2,980,150 9,235,485
2016-05-23 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.10 2,800 2,961,450 9,180,495
2016-05-12 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.10 18,500 2,958,650 9,171,815
2016-05-10 4 ALLEN ANTHONY C A D 3.1900 21,943 21,943
2016-05-10 4 CONNOLLY PAT A D 3.1900 21,943 77,714
2016-05-10 4 MCBRIDE KENNETH THOMAS A D 3.1900 21,943 21,943
2016-05-10 4 Buss Brad W A D 3.1900 21,943 76,353
2016-05-11 4 Durham Fred E. III P D 3.1154 2,107 2,215,914 6,903,458
2016-05-10 4 Swinmurn Nick A D 3.1900 21,943 21,943
2016-05-10 4 Durham Fred E. III P D 3.1400 2,107 2,213,807 6,951,354
2016-04-22 4 Durham Fred E. III A D 3.7400 72,000 2,211,700
2016-04-22 4 Jain Maheesh A D 3.7400 22,000 22,000
2016-04-22 4 Jackson Garett A D 3.7400 22,000 78,965
2016-03-07 4 Durham Fred E. III P D 3.8500 4,877 4,274,523 16,456,914
2016-03-03 4 Durham Fred E. III P D 3.8800 4,693 4,274,523 16,585,149
2016-02-08 4 MILLER LLOYD I III By Trust A-4 - Lloyd I. Miller P I 3.10 450 2,940,150 9,114,465
2016-01-20 4 MILLER LLOYD I III By Milfam III L.P. P I 3.10 5,100 2,939,700 9,113,070
2016-01-19 4 MILLER LLOYD I III By Milfam III L.P. P I 3.10 14,600 2,934,600 9,097,260
2016-01-15 4 MILLER LLOYD I III By Trust D - Lloyd I. Miller P I 3.10 10,400 2,920,000 9,052,000
2015-12-22 4 MILLER LLOYD I III By LIMFAM LLC P I 3.60 2,800 2,909,600 10,474,560
2015-12-21 4 MILLER LLOYD I III By LIMFAM LLC P I 3.60 29,800 2,906,800 10,464,480
2015-12-18 4 MILLER LLOYD I III By LIMFAM LLC P I 3.70 1,300 2,877,000 10,644,900
2015-12-17 4 MILLER LLOYD I III By LIMFAM LLC P I 3.7477 19,500 2,875,700 10,777,261
2015-12-16 4 MILLER LLOYD I III P D 3.75 6,400 2,856,200 10,710,750
2015-11-20 4 Durham Fred E. III P D 4.00 5,899 2,130,130 8,520,520
2015-11-19 4 Durham Fred E. III P D 4.0841 5,899 2,124,231 8,675,572
2015-11-18 4 Durham Fred E. III P D 3.9283 5,899 2,118,332 8,321,444
2015-11-17 4 MILLER LLOYD I III P D 3.8385 17,400 2,849,800 10,938,957
2015-11-13 4 MILLER LLOYD I III P D 3.875 32,600 2,832,400 10,975,550
2015-11-03 4 Jackson Garett F D 4.7076 -519 56,965
2015-10-19 4 MILLER LLOYD I III P D 4.25 1,500 2,799,800 11,899,150
2015-10-12 4 MILLER LLOYD I III P D 4.25 12,300 2,798,300 11,892,775
2015-10-07 4 MILLER LLOYD I III P D 4.25 700 2,786,000 11,840,500
2015-09-29 4 MILLER LLOYD I III P D 4.25 6,100 2,785,300 11,837,525
2015-09-24 4 Jackson Garett F D 4.30 -5 57,484
2015-09-24 4 Jackson Garett F D 4.3325 -452 57,489
2015-09-14 4 MILLER LLOYD I III P D 4.30 13,400 2,779,200 11,950,560
2015-09-08 4 MILLER LLOYD I III P D 4.25 2,500 2,765,800 11,754,650
2015-09-03 4 MILLER LLOYD I III P D 4.30 13,900 2,763,300 11,882,190
2015-09-03 4 Durham Fred E. III P D 4.2999 176 2,112,433 9,083,251
2015-09-02 4 Durham Fred E. III P D 4.4754 5,122 2,112,257 9,453,195
2015-08-31 4 MILLER LLOYD I III P D 4.25 10,000 2,749,400 11,684,950
2015-08-28 4 Durham Fred E. III P D 4.4756 5,216 2,107,135 9,430,693
2015-08-27 4 Durham Fred E. III P D 4.4494 5,216 2,101,919 9,352,278
2015-08-26 4 Durham Fred E. III P D 4.4825 5,216 2,096,703 9,398,471
2015-08-19 4 Jackson Garett F D 4.68 -315 57,941
2015-07-31 4 Jackson Garett F D 4.36 -498 58,256
2015-05-20 4 Jackson Garett F D 4.02 -419 55,229
2015-04-06 4 Jackson Garett F D 3.95 -468 32,648
2015-04-01 4 Jackson Garett F D 3.90 -298 33,116
2014-12-26 4 Jackson Garett F D 2.3198 -522 33,414
2014-12-26 4 Jackson Garett F D 2.3201 -15 33,936
2014-09-30 4 Jackson Garett F D 3.2267 -524 33,951
2014-09-30 4 Jackson Garett F D 3.20 -5 34,475
2015-07-13 4 Jackson Garett F D 4.54 -475 58,754
2015-06-08 4 Jackson Garett P D 4.78 4,000 23,480 112,234
2015-06-04 4 Durham Fred E. III P D 4.65 19,800 1,979,054 9,202,601
2015-06-04 4 Durham Fred E. III P D 4.64 300 1,959,254 9,090,939
2015-06-04 4 Durham Fred E. III P D 4.63 400 1,958,954 9,069,957
2015-06-04 4 Durham Fred E. III P D 4.58 400 1,958,554 8,970,177
2015-06-04 4 Durham Fred E. III P D 4.56 100 1,958,154 8,929,182
2015-06-03 4 Durham Fred E. III P D 4.50 20,430 1,958,054 8,811,243
2015-06-03 4 Durham Fred E. III P D 4.49 200 1,937,624 8,699,932
2015-06-03 4 Durham Fred E. III P D 4.48 270 1,937,424 8,679,660
2015-06-03 4 Durham Fred E. III P D 4.47 100 1,937,154 8,659,078
2015-06-02 4 Durham Fred E. III P D 4.50 100 1,937,054 8,716,743
2015-06-02 4 Durham Fred E. III P D 4.46 100 1,936,954 8,638,815
2015-06-02 4 Durham Fred E. III P D 4.44 600 1,936,854 8,599,632
2015-06-02 4 Durham Fred E. III P D 4.42 100 1,936,254 8,558,243
2015-06-02 4 Durham Fred E. III P D 4.40 7,300 1,936,154 8,519,078
2015-06-02 4 Durham Fred E. III P D 4.39 10,600 1,928,854 8,467,669
2015-06-02 4 Durham Fred E. III P D 4.36 1,100 1,918,254 8,363,587
2015-06-02 4 Durham Fred E. III P D 4.35 800 1,917,154 8,339,620
2015-06-02 4 Durham Fred E. III P D 4.34 100 1,916,354 8,316,976
2015-06-02 4 Durham Fred E. III P D 4.33 200 1,916,254 8,297,380
2015-06-01 4 Durham Fred E. III P D 4.49 2,279 1,916,054 8,603,082
2015-06-01 4 Durham Fred E. III P D 4.48 4,925 1,913,775 8,573,712
2015-06-01 4 Durham Fred E. III P D 4.47 1,800 1,908,850 8,532,560
2015-06-01 4 Durham Fred E. III P D 4.44 1,002 1,907,050 8,467,302
2015-06-01 4 Durham Fred E. III P D 4.43 1,500 1,906,048 8,443,793
2015-06-01 4 Durham Fred E. III P D 4.42 2,300 1,904,548 8,418,102
2015-06-01 4 Durham Fred E. III P D 4.41 1,100 1,902,248 8,388,914
2015-06-01 4 Durham Fred E. III P D 4.40 100 1,901,148 8,365,051
2015-06-01 4 Durham Fred E. III P D 4.32 5,094 1,901,048 8,212,527
2015-06-01 4 Durham Fred E. III P D 4.31 300 1,895,954 8,171,562
2015-06-01 4 Durham Fred E. III P D 4.30 500 1,895,654 8,151,312
2015-06-01 4 Durham Fred E. III P D 4.28 100 1,895,154 8,111,259
2015-05-21 4 Durham Fred E. III P D 4.20 5,761 1,895,054 7,959,227
2015-05-21 4 Durham Fred E. III P D 4.19 600 1,889,293 7,916,138
2015-05-21 4 Durham Fred E. III P D 4.18 1 1,888,693 7,894,737
2015-05-21 4 Durham Fred E. III P D 4.16 200 1,888,692 7,856,959
2015-05-21 4 Durham Fred E. III P D 4.15 700 1,888,492 7,837,242
2015-05-21 4 Durham Fred E. III P D 4.14 400 1,887,792 7,815,459
2015-05-21 4 Durham Fred E. III P D 4.13 200 1,887,392 7,794,929
2015-05-21 4 Durham Fred E. III P D 4.12 200 1,887,192 7,775,231
2015-05-21 4 Durham Fred E. III P D 4.11 8,738 1,886,992 7,755,537
2015-05-21 4 Durham Fred E. III P D 4.10 3,000 1,878,254 7,700,841
2015-05-21 4 Durham Fred E. III P D 4.09 600 1,875,254 7,669,789
2015-05-21 4 Durham Fred E. III P D 4.07 300 1,874,654 7,629,842
2015-05-21 4 Durham Fred E. III P D 4.05 200 1,874,354 7,591,134
2015-05-21 4 Durham Fred E. III P D 4.04 100 1,874,154 7,571,582
2015-05-20 4 Durham Fred E. III P D 3.90 14,649 1,874,054 7,308,811
2015-05-20 4 Durham Fred E. III P D 3.89 1,351 1,859,405 7,233,085
2015-05-20 4 Durham Fred E. III P D 3.88 5,000 1,858,054 7,209,250
2015-05-18 4 LEONE DOUGLAS M A D 16,908 2,955,265
2015-05-18 4 CONNOLLY PAT A D 16,908 55,771
2015-05-18 4 Buss Brad W A D 16,908 54,410
2015-03-26 4 MILLER LLOYD I III P D 3.40 61,900 2,739,400 9,313,960
2015-03-12 4 MILLER LLOYD I III P D 3.40 7,200 2,677,500 9,103,500
2015-03-10 4 MILLER LLOYD I III P D 3.3801 2,100 2,670,300 9,025,881
2015-03-05 4 MILLER LLOYD I III P D 3.20 200 2,668,200 8,538,240
2015-03-04 4 MILLER LLOYD I III P D 3.20 92,200 2,668,000 8,537,600
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...